Suvretta reports 11.7% passive stake in InflaRx
InflaRx N.V. received an updated ownership disclosure showing Suvretta Capital–related entities holding a significant passive stake in the company’s common shares.
Rhea-AI Filing Summary
InflaRx N.V. received an updated ownership disclosure showing Suvretta Capital–related entities holding a significant passive stake in the company’s common shares. As of December 31, 2025, Suvretta Capital Management, LLC and its founder Aaron Cowen each report beneficial ownership of 7,933,910 common shares, representing 11.7% of the class, while Averill Master Fund, Ltd. reports 7,723,710 shares, or 11.4%.
The shares are directly owned by advisory clients of Suvretta, with Averill as the only client holding more than 5% individually. The filers certify the holdings were not acquired for the purpose of changing or influencing control of InflaRx and are reported on a passive Schedule 13G/A basis.
Positive
- None.
Negative
- None.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What ownership stake in InflaRx (IFRX) is reported by Suvretta Capital?
What is Aaron Cowen’s reported beneficial ownership in InflaRx (IFRX)?
Is the Suvretta stake in InflaRx (IFRX) filed as passive or active?
What disclaimer about beneficial ownership do the InflaRx (IFRX) reporting persons make?
AI-generated analysis. How Rhea-AI works. Not financial advice.